Targeted therapy can delay recurrence of intermediate-stage lung cancer

(American Society of Clinical Oncology) The targeted therapy gefitinib appears more effective in preventing recurrence after lung cancer surgery than the standard of care, chemotherapy.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news